Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival

Table 1

Patients’ characteristics.

		%
Age at diagnosis
<18 months	0
>18 months	41	100
Sex
Female	17	41.5
Male	24	58.5
MYCN status
Amplified	13	31.7
Not amplified	28	68.3
Primary tumor site
Adrenal	25	61.0
Thorax	3	7.3
Abdomen	13	31.7
Metastatic sites
Bone Marrow	13	31.7
Bone Marrow + bone	24	58.6
Pleura	2	4.9
Bone	1	2.4
Other	1	2.4
Relapse
No	15	36.6
Yes	26	63.4
Outcome
Alive	16	39.0
Dead of disease	25	61.0